Abstract
In clinical trials, subjects are often classified into ordered categories (eg, worsening, no change, and improvement) based on their post-treatment clinical response changes from baseline. The usual approach in using a multinomial model for assessing treatment effects between treatment groups is not efficient because it demands intense computation to evaluate the corresponding probabilities across these ordered categories. In this study, we propose to model the response probabilities via a parametric form, and the comparison of these probabilities is translated into the comparison of the associated model parameters. Maximum likelihood estimates are then derived and the required sample size for achieving a desired statistical power at a prespecified level of significance is also obtained. A simulation study is performed to evaluate finite sample size performance. An example concerning the evaluation of the efficacy of a test treatment for subjects with moderate to severe Crohn disease that is refractory to steroids and immunosuppressants is presented to illustrate the proposed method.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.